What's breaking now, across thousands of outlets.
Dr Stavros Nicolaou, chairman of Pharmisa and director at Aspen, talks about the increases in the cost and production of medicine.
We haven't written up this one. Moneyweb has the full story — the link below goes straight to it.
(MedPage Today) -- The FDA expanded the indications for the B-cell depleter obinutuzumab (Gazyva) to include idiopathic nephrotic syndrome, the agency announced on Friday, the first new option for the…
The United States rejected a nonbinding United Nations declaration pledging international collaboration to improve pandemic preparedness and prevention, joining the European Union in objecting to the…
The National Health Insurance Authority has called for a locally led health financing research agenda to guide reforms and improve healthcare access for Ni Read More…
A noninvasive technique that stimulates nerves through the ear has been shown to be safe, well tolerated and easy for patients with uncontrolled high blood pressure to use at home, according to a…
The National Health Insurance Authority has called for a locally led health financing research agenda to guide reforms and improve healthcare access for Ni Read More…
New Patriotic Party (NPP) Flagbearer Dr Mahamudu Bawumia has engaged the leadership of the Ghana Medical Association (GMA) on challenges confronting Ghana’s health sector, including the retention of…
